ISIN | CH0226525399 |
---|---|
Valor Number | 22652539 |
Bloomberg Global ID | BCVSWCP SW |
Fund Name | AMC PROFESSIONAL FUND - BCV Swiss Equity ESG CP |
Fund Provider |
Banque Cantonale Vaudoise
Lausanne, Switzerland Phone: +41 848 808 880 E-Mail: info@bcv.ch Web: www.bcv.ch |
Fund Provider | Banque Cantonale Vaudoise |
Representative in Switzerland | |
Distributor(s) |
Banque Cantonale Vaudoise Lausanne Phone: +41 21 212 10 00 |
Asset Class | Equities |
EFC Category | |
Distribution Policy | Accumulation |
Home Country | Switzerland |
Issuing Condition | The fund charges a transaction fee (contribution towards expenses incurred in the investment of new assets) |
Redemption Condition | The fund charges a transaction fee (contribution towards covering expenses incurred in the sale of assets) |
Investment Strategy *** | The objective of the BCV Swiss Equity is to achieve long-term capital appreciation. The Subfund is highly diversified. It seeks the best investment opportunities relying on a management approach that combines qualitative, fundamental, and behavioral analysis. The Subfund invests in equities and uncertificated securities (shares, dividend certificates, membership shares, participation certificates, and similar) of Swiss domiciled companies, or those carrying out a predominant part of their business activity in Switzerland. Companies can be of any size capitalization. The portion allocated to collective investments is limited to a maximum 10% of the Subfund's assets. |
Peculiarities |
Current Price * | 242.92 CHF | 02.10.2025 |
---|---|---|
Previous Price * | 241.19 CHF | 01.10.2025 |
52 Week High * | 246.90 CHF | 03.03.2025 |
52 Week Low * | 207.16 CHF | 09.04.2025 |
NAV * | 242.92 CHF | 02.10.2025 |
Issue Price * | ||
Redemption Price * | ||
Closing Price * | ||
Indicative Minimum Price | ||
Fund Assets *** | 564,430,071 | |
Unit/Share Assets *** | 5,320,994 | |
Trading Information SIX |
YTD Performance | +9.95% |
31.12.2024 - 02.10.2025
31.12.2024 02.10.2025 |
---|---|---|
1 month | +2.02% |
02.09.2025 - 02.10.2025
02.09.2025 02.10.2025 |
3 months | +2.86% |
02.07.2025 - 02.10.2025
02.07.2025 02.10.2025 |
6 months | +1.85% |
02.04.2025 - 02.10.2025
02.04.2025 02.10.2025 |
1 year | +5.42% |
02.10.2024 - 02.10.2025
02.10.2024 02.10.2025 |
2 years | +20.75% |
02.10.2023 - 02.10.2025
02.10.2023 02.10.2025 |
3 years | +30.25% |
03.10.2022 - 02.10.2025
03.10.2022 02.10.2025 |
5 years | +31.78% |
02.10.2020 - 02.10.2025
02.10.2020 02.10.2025 |
Equity Participation Rate in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Share of Total Fund Assets in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Real Estate Rate in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ADDI | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ADDI Date |
Roche Holding AG | 12.31% | |
---|---|---|
Novartis AG Registered Shares | 12.14% | |
Nestle SA | 11.86% | |
UBS Group AG Registered Shares | 5.94% | |
Zurich Insurance Group AG | 5.31% | |
ABB Ltd | 5.17% | |
Compagnie Financiere Richemont SA Class A | 4.69% | |
Sandoz Group AG Registered Shares | 3.95% | |
Swiss Re AG | 2.73% | |
Lonza Group Ltd | 2.57% | |
Last data update | 31.08.2025 |
TER | 0.36% |
---|---|
TER date | 31.03.2025 |
Performance Fee *** | |
PTR | |
Max. Management Fee *** | 0.50% |
Ongoing Charges *** | 0.36% |
SRRI ***
|
|
SRRI date *** | 30.09.2025 |